A Study to Assess Cardiovascular Outcomes Following Treatment With Omarigliptin (MK-3102) in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Clinical trial NCT01703208 · TERMINATED
Trial details
- NCT number
- NCT01703208
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-10-05
- Primary completion
- 2016-05-13
- Enrollment
- 4202
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.